June 24, 2020 / 1:17 AM / 20 days ago

BRIEF-Mayne Pharma Announces FDA Filing Acceptance Of E4/DRSP In U.S.

June 24 (Reuters) - Mayne Pharma Group Ltd:

* ANNOUNCES FDA FILING ACCEPTANCE OF E4/DRSP IN US

* FDA IS EXPECTED TO COMPLETE ITS REVIEW IN FIRST HALF OF CALENDAR 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below